Needle-free insulin injection improves blood sugar control and reduces pain in hospitalized type 2 diabetes patients
May 7, 2026
Highly relevant
Interventions:
Strength:
What Improves Glycemic Control in Diabetes? Evidence-Based Strategies
Evidence on improving glycemic control
Evidence related to blood glucose control, fasting glucose, postprandial glucose, glucose variability, and time in range.
30
Studies
63
Evidence Pairs
High Confidence
Quality: 83/100
Supporting Studies
30
Research documents analyzed
Evidence Pairs
63
Intervention-outcome relationships
Latest Publication
May 2026
Avg. Evidence: 42/100
Evidence Snapshot
Qualitative overview of the evidence landscape
Moderate Confidence
Practical Questions
What improves glycemic control?
outcome achievementMetformin, Pioglitazone, Tirzepatide are among the most frequently studied approaches, studied in the available research.
Does Metformin improve glycemic control?
intervention effectivenessResearch shows Metformin has been studied in relation to 8 different outcomes with limited evidence.
Does Pioglitazone improve glycemic control?
intervention effectivenessResearch shows Pioglitazone has been studied in relation to 8 different outcomes with limited evidence.
Does Tirzepatide improve glycemic control?
intervention effectivenessResearch shows Tirzepatide has been studied in relation to 8 different outcomes with limited evidence.
Metformin vs Pioglitazone for glycemic control?
compareBoth Metformin and Pioglitazone have documented evidence for Glycemic Control. Review the evidence table to compare specific outcomes and study quality.
How can I lower glycemic control?
sub outcomeMetformin, Pioglitazone, Tirzepatide are among the most frequently studied approaches, studied in the available research.
Which interventions need more research for glycemic control?
research gaps, , have limited research (fewer than 5 studies) and would benefit from additional investigation.
Top evidence-backed options for this outcome
Interventions with the strongest supporting evidence in our database
Metformin
2 studies
View evidence
Pioglitazone
1 study
View evidence
Tirzepatide
1 study
View evidence
American ginseng
1 study
View evidence
Low-carbohydrate diet
2 studies
View evidence
Insulin degludec
2 studies
View evidence
Metformin + glimepiride
2 studies
View evidence
Glibenclamide
1 study
View evidence
Xiaoke
1 study
View evidence
Calorie restriction
1 study
View evidence
Note: Evidence strength is calculated from multiple factors including study quality, consistency, and effect sizes. Click any option to explore the supporting research in our archive.
Strongest evidence signals
Key patterns and insights identified across the research landscape
Moderate positive signal
Metformin may improve Fasting Plasma Glucose
Metformin → Fasting Plasma Glucose
Across 2 studies, Metformin shows a consistent moderate positive signal for Fasting Plasma Glucose.
2 studies
Moderate positive signal
Pioglitazone may improve Fasting Plasma Glucose
Pioglitazone → Fasting Plasma Glucose
Across 1 study, Pioglitazone shows a moderate positive signal for Fasting Plasma Glucose.
1 studies
Moderate positive signal
Tirzepatide may improve Fasting Plasma Glucose
Tirzepatide → Fasting Plasma Glucose
Across 1 study, Tirzepatide shows a moderate positive signal for Fasting Plasma Glucose.
1 studies
Supporting Research
Selected studies that best represent the evidence behind this topic.
View research summary→
Newer diabetes drugs show stronger weight and blood sugar benefits in prediabetes
May 16, 2026
High quality
Interventions:
Outcomes:
Strength:
Hybrid closed-loop artificial pancreas system improves blood sugar control better than insulin injections in hospitalized type 1 diabetes
May 15, 2026
Recent
Interventions:
Strength:
Pilot protocol compares Ayurvedic Nimba-Amalakyadi powder versus metformin for type 2 diabetes
May 26, 2026
Recent
Interventions:
Strength:
Natural products may improve blood sugar and cardiovascular risk markers in type 2 diabetes
May 26, 2026
Recent
Interventions:
Outcomes:
Strength:
Early insulin degludec with IV insulin infusion speeds DKA resolution by 3.25 hours without increasing hypoglycaemia risk
May 13, 2026
Recent
Interventions:
Outcomes:
Strength:
Click any study to view the full research summary, or click interventions and outcomes to filter the archive.
Related Evidence Topics
Explore related evidence areas connected by shared studies, interventions, or outcomes.
Explore all supporting studies
Browse the complete evidence archive for this topic, including interventions, outcomes, and related research. Use powerful filters to find exactly what you're looking for.
View All Supporting StudiesFilter by study type, publication date, effect size, and more to refine your research